Daniel Sherman is a Senior Consultant at Simon-Kucher since June 2021, where expertise includes advising Fortune 500 pharmaceutical clients on drug pricing, market access, and competitive strategies. Proficient in data analysis using R, Python, and Excel, Daniel builds models for revenue optimization and manages project work streams. Previous experiences include roles at Massachusetts General Hospital as a Clinical Engineering Intern, at Sanofi Genzyme in various intern positions focusing on human economics and patient outcomes, and research at Harvard's engineering school. Daniel holds a Bachelor of Arts in Bioengineering and Biomedical Engineering from Harvard University, complemented by a study abroad experience in Sustainable Urban Development.